Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hoffer

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Psychopharmacology|December 1, 1995
Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addictsR T Malison, S E Best, E A Wallace, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796J P Seibyl, Y Zea-Ponce, L Brenner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1994
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjectsM Laruelle, E Wallace, J P Seibyl, et al.
European Journal of Neurology|November 29, 2013
Long-term beneficial effects of adrenal medullary autografts supported by nerve growth factor in Parkinson's diseaseO Sydow, P Hansson, D Young, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Neurology|January 1, 1996
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseK L Marek, J P Seibyl, S S Zoghbi, et al.
Nuclear Medicine and Biology|April 8, 2000
[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primatesB E Scanley, M S Gandelman, M Laruelle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
SPECT imaging of striatal dopamine release after amphetamine challengeM Laruelle, A Abi-Dargham, C H van Dyck, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experimentsM Laruelle, R M Baldwin, Z Rattner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's diseaseC H van Dyck, C H Lin, E O Smith, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Psychopharmacology|December 1, 1995
Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addictsR T Malison, S E Best, E A Wallace, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796J P Seibyl, Y Zea-Ponce, L Brenner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1994
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjectsM Laruelle, E Wallace, J P Seibyl, et al.
European Journal of Neurology|November 29, 2013
Long-term beneficial effects of adrenal medullary autografts supported by nerve growth factor in Parkinson's diseaseO Sydow, P Hansson, D Young, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Neurology|January 1, 1996
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseK L Marek, J P Seibyl, S S Zoghbi, et al.
Nuclear Medicine and Biology|April 8, 2000
[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primatesB E Scanley, M S Gandelman, M Laruelle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
SPECT imaging of striatal dopamine release after amphetamine challengeM Laruelle, A Abi-Dargham, C H van Dyck, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experimentsM Laruelle, R M Baldwin, Z Rattner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's diseaseC H van Dyck, C H Lin, E O Smith, et al.
Pageof 18